logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10584317 B1

PDFFull Text
Date of Patent:
Mar. 10, 2020

Filed:

Mar. 02, 2018

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

Applicant:

Genelux Corporation, San Diego, CA (US);

Inventors:

Aladar A. Szalay, Wilmington, DE (US);

Alexa Frentzen, San Diego, CA (US);

Yong A. Yu, San Diego, CA (US);

Nanhai Chen, San Diego, CA (US);

Qian Zhang, San Diego, CA (US);

Assignee:

Genelux Corporation, San Diego, CA (US);

Attorneys:

Dentons US LLP

Stephanie Seidman

Primary Examiner:

Bao Q Li

Int. Cl.
CPC ...
C12N 7/00 (2006.01); A61K 39/12 (2006.01); A61K 38/48 (2006.01); A61K 9/00 (2006.01); A61K 31/282 (2006.01); A61K 31/4745 (2006.01); A61K 31/7068 (2006.01); A61K 33/24 (2019.01); A61K 38/17 (2006.01); A61K 38/20 (2006.01); A61K 39/285 (2006.01); A61K 45/06 (2006.01); A61K 48/00 (2006.01); A61K 49/00 (2006.01); A61K 49/14 (2006.01); A61K 49/18 (2006.01); C07K 14/005 (2006.01); C07K 14/54 (2006.01); C07K 16/22 (2006.01); C12N 15/86 (2006.01); C12Q 1/04 (2006.01); G01N 33/574 (2006.01); G01N 33/58 (2006.01); A61K 38/36 (2006.01); A61K 35/76 (2015.01); A61K 39/395 (2006.01); C07K 14/47 (2006.01); C07K 14/715 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C12N 7/00 (2013.01); A61K 9/0019 (2013.01); A61K 31/282 (2013.01); A61K 31/4745 (2013.01); A61K 31/7068 (2013.01); A61K 33/24 (2013.01); A61K 35/76 (2013.01); A61K 38/1709 (2013.01); A61K 38/1793 (2013.01); A61K 38/20 (2013.01); A61K 38/204 (2013.01); A61K 38/36 (2013.01); A61K 38/484 (2013.01); A61K 39/12 (2013.01); A61K 39/285 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61K 48/0058 (2013.01); A61K 49/0008 (2013.01); A61K 49/0045 (2013.01); A61K 49/0047 (2013.01); A61K 49/0097 (2013.01); A61K 49/14 (2013.01); A61K 49/1896 (2013.01); C07K 14/005 (2013.01); C07K 14/47 (2013.01); C07K 14/54 (2013.01); C07K 14/5412 (2013.01); C07K 14/7155 (2013.01); C07K 16/22 (2013.01); C12N 15/86 (2013.01); C12Q 1/04 (2013.01); G01N 33/574 (2013.01); G01N 33/585 (2013.01); A61K 48/00 (2013.01); A61K 2039/523 (2013.01); A61K 2039/5254 (2013.01); A61K 2039/5256 (2013.01); C07K 2317/622 (2013.01); C07K 2317/73 (2013.01); C07K 2319/00 (2013.01); C07K 2319/20 (2013.01); C07K 2319/60 (2013.01); C07K 2319/61 (2013.01); C07K 2319/74 (2013.01); C12N 2710/14171 (2013.01); C12N 2710/24121 (2013.01); C12N 2710/24122 (2013.01); C12N 2710/24132 (2013.01); C12N 2710/24141 (2013.01); C12N 2710/24143 (2013.01); C12N 2710/24162 (2013.01);
Abstract

Modified viruses and methods for preparing the modified viruses are provided. Vaccines that contain the viruses are provided. The viruses can be used in methods of treatment of diseases, such as proliferative and inflammatory disorders, including cancer, and as anti-tumor and/or antiangiogenic agents. The viruses also can be used in diagnostic methods.

Find Patent Forward Citations

Szalay, Aladar. (2020). Modified vaccinia virus strains for use in diagnostic and therapeutic methods (U.S. Patent No. 10584317). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10584317

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…